Market Research Life Sciences Market Research Pharmaceuticals Market Research Biopharmaceuticals Market Research

India Pharmaceutical Contract Sales Organizations Market Size, Share & Trends Analysis Report By Service (Personal, Non-personal Promotion), By End-use (Pharmaceutical Companies, Biopharmaceutical Companies), And Segment Forecasts, 2024 - 2030

Best Price Guarantee Length Publisher Published Date SKU
from $3,950 90 Pages Grand View Research December, 2023 GV18532143
Best Price Guarantee
Price from $3,950
Length 90 Pages
Publisher Grand View Research
Published Date December, 2023
SKU GV18532143

India Pharmaceutical Contract Sales Organizations Market Size, Share & Trends Analysis Report By Service (Personal, Non-personal Promotion), By End-use (Pharmaceutical Companies, Biopharmaceutical Companies), And Segment Forecasts, 2024 - 2030


India Pharmaceutical Contract Sales Organizations Market Growth & Trends

The India pharmaceutical contract sales organizations market size is anticipated to reach USD 575.2 million by 2030 and is anticipated to grow at a CAGR of 7.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing pharmaceutical industry, pharmaceutical product approval, and commercialization are the major factors contributing to the market growth. As per the Indian Ministry of Health and Family Welfare, in 2022, the pharmaceutical sector in India comprised 3,000 drug companies and 10,500 manufacturing units.

The increasing outsourcing trends in the Indian pharmaceutical industry has propelled market expansion. Many companies use outsourcing research to India, appealing due to its advantages and benefits. The competitive pricing of services in India enables significant cost reduction for companies, providing them access to the market. A rising trend involves incorporating technology into outsourcing. Technological advancements like artificial intelligence, machine learning, and automation are reshaping the pharmaceutical industry, with CSOs leveraging these advancements to enhance their services.

Furthermore, strong government support and rising pharmaceutical R&D spending is expected to drive the market growth. For instance, in April 2023, the Indian government planned to enhance research and innovation in India's pharmaceuticals and medical technology sectors through a five-year program with a budget of USD 599.99 million. This development holds significance as research and development (R&D) constitute only 7% of the overall expenditure in the Indian pharmaceutical industry, in contrast to the over 35% observed in developed countries.

India Pharmaceutical Contract Sales Organizations Market Report Highlights
  • In terms of service, the non-personal promotion segment dominated the service segment with more than 56.0% share in 2023 owing to its efficiency and cost-effectiveness
  • The personal promotion segment is also expected to show a significant share in the market. This is attributed to complex products and services
  • In terms of end-use, the pharmaceutical companies segment held the largest market share in 2023. The increase in the number of new small molecule drug launches is anticipated to be a major driving factor for the market growth
  • The biopharmaceutical companies’ segment is expected to grow at the fastest CAGR over the forecast period
Please note The report will be delivered in 4-6 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. End-use
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in India
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Service outlook
2.2.2. End Use outlook
2.3. Competitive Insights
Chapter 3. India Pharmaceutical Contract Sales Organizations Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing pharmaceutical outsourcing trends
3.2.1.2. Increased pharmaceutical industry complexity
3.2.1.3. Enhanced sales force effectiveness
3.2.2. Market restraint analysis
3.2.2.1. Data security and privacy concerns
3.2.2.2. Dependency on client companies
3.3. India Pharmaceutical Contract Sales Organizations Market Analysis Tools
3.3.1. Industry analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. India Pharmaceutical Contract Sales Organizations Market: Service Business Analysis
4.1. India Pharmaceutical Contract Sales Organizations Market, By Service: Segment Dashboard
4.2. India Pharmaceutical Contract Sales Organizations Market, By Service: Movement Analysis
4.3. India Pharmaceutical Contract Sales Organizations Market Estimates & Forecasts, By Service, 2018 - 2030
4.3.1. Personal Promotion
4.3.1.1. India Personal Promotion Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
4.3.1.2. Promotional Sales Team
4.3.1.2.1 India Promotional Sales Team Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
4.3.1.3. Key Account Management
4.3.1.3.1 India Key Account Management Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
4.3.1.4. Vacancy Management
4.3.1.4.1 India Vacancy Management Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
4.3.2. Non-personal Promotion
4.3.2.1. India Non-personal Promotion Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
4.3.2.2. Medical Affairs Solutions
4.3.2.2.1 India Medical Affairs Solutions Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
4.3.2.3. Remote Medical Science Liaisons
4.3.2.3.1. India Remote Medical Science Liaisons Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
4.3.2.4. Nurse (Clinical) Educators
4.3.2.4.1. India Nurse (Clinical) Educators Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
4.3.2.5. Others
4.3.2.5.1. India Others Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
Chapter 5. India Pharmaceutical Contract Sales Organizations Market: End-use Business Analysis
5.1. India Pharmaceutical Contract Sales Organizations Market, By End-use: Segment Dashboard
5.2. India Pharmaceutical Contract Sales Organizations Market, By End-use: Movement Analysis
5.3. India Pharmaceutical Contract Sales Organizations Market Estimates & Forecasts, By End-use, 2018 - 2030
5.3.1. Pharmaceutical Companies
5.3.1.1. India Pharmaceutical Companies Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
5.3.2. Biopharmaceutical Companies
5.3.2.1. India Biopharmaceutical Companies Pharmaceutical Contract Sales Organizations Market, 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Heat Map Analysis
6.3. Company Categorization
6.4. Strategy Mapping
6.4.1. Merger& Acquisition
6.4.2. Collaborations
6.4.3. New Product Launch
6.5. Participant’s overview
6.5.1. IQVIA Inc.
6.5.1.1. Overview
6.5.1.2. Financial Performance
6.5.1.3. Product Benchmarking
6.5.1.4. Strategic Initiatives
6.5.2. Syneos Health
6.5.2.1. Overview
6.5.2.2. Financial Performance
6.5.2.3. Product Benchmarking
6.5.2.4. Strategic Initiatives
6.5.3. Parexel International (MA) Corporation
6.5.3.1. Overview
6.5.3.2. Financial Performance
6.5.3.3. Product Benchmarking
6.5.3.4. Strategic Initiatives
6.5.4. Mednext Pharma Private Limited
6.5.4.1. Overview
6.5.4.2. Financial Performance
6.5.4.3. Product Benchmarking
6.5.4.4. Strategic Initiatives
6.5.5. Indegene
6.5.5.1. Overview
6.5.5.2. Financial Performance
6.5.5.3. Product Benchmarking
6.5.5.4. Strategic Initiatives
6.5.6. ICON plc
6.5.6.1. Overview
6.5.6.2. Financial Performance
6.5.6.3. Product Benchmarking
6.5.6.4. Strategic Initiatives
6.5.7. PPD (Thermo Fisher Scientific Inc.)
6.5.7.1. Overview
6.5.7.2. Financial Performance
6.5.7.3. Product Benchmarking
6.5.7.4. Strategic Initiatives
6.5.8. QFR Solutions
6.5.8.1. Overview
6.5.8.2. Financial Performance
6.5.8.3. Product Benchmarking
6.5.8.4. Strategic Initiatives
6.5.9. LabCorp
6.5.9.1. Overview
6.5.9.2. Financial Performance
6.5.9.3. Product Benchmarking
6.5.9.4. Strategic Initiatives
6.5.10. Makrocare
6.5.10.1. Overview
6.5.10.2. Financial Performance
6.5.10.3. Product Benchmarking
6.5.10.4. Strategic Initiatives

$3,950
$4,950
$6,950

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings